Start with one number from the Bureau of Labor Statistics, because it tells the whole story. In the May 2025 OEWS data, Chief Executives (SOC 11-1011) earn $75,700 at the 10th percentile and $507,730 at the 90th. That is a 6.7x spread inside a single occupation — the widest of any executive role we track. Some of that is company size. Most of it is the cash-versus-equity tradeoff made visible. The CEO at the 10th percentile is very often a founder paying herself $75k while sitting on 30% of a company. The one at the 90th is a hired operator who negotiated for cash because the equity upside was already spoken for. Neither is wrong. But only one of them chose deliberately, and after thirty years of watching these negotiations, I can tell you the deliberate ones end up richer.
The same pattern runs down the org chart. A CTO in San Francisco sits in the most equity-saturated market in the country, where cash comp is only half the conversation; our national CTO cash band runs $148k at the 10th percentile to $415k at the 90th, and equity routinely exceeds the salary line entirely. So the real question is never "what's the salary?" It's "what am I actually being paid, in what instrument, at what risk, on what timeline?" Here is how to answer it.
Know the Instrument Before You Price It
Executives lose money by treating all equity as one thing. It is at least three things, and they behave nothing alike.
Stock options are a leveraged bet. You get the right to buy shares at a strike price; your gain is the spread between strike and eventual sale price. If the company doubles, early options can 10x. If the company treads water, options are worth zero — not "less," zero. Options are the right instrument when you genuinely believe in a big move and you're early enough for the strike to be low.
RSUs are deferred cash denominated in stock. They're worth something at any share price above zero, which is why late-stage and public companies use them. An RSU package is a salary you can't spend for four years, with market beta attached. Price it like comp, not like a lottery ticket.
Profit interests — common in PE-backed and LLC structures — pay you a share of value created above a hurdle. They can be spectacular in a good exit and they are the easiest instrument in this list to misunderstand, because the hurdle, the vesting, and the sponsor's preferred return all sit in documents you have to ask for. A GM taking a PE-backed operating role in Chicago should read the equity plan the way the sponsor's lawyers wrote it: as a contract, not a promise.
Pricing Private Equity: The Four Questions
Public stock has a ticker. Private stock has a story, and your job is to convert the story into a number. Four questions do it.
What's the 409A, and what's the preferred price? The 409A valuation sets your option strike; the preferred price is what investors actually paid. The gap between them is your built-in spread — and your built-in risk. If the last round priced preferred at $18 and your strike is $6, good. If the 409A is stale or the last round was two years ago, the "current valuation" everyone quotes is fiction with a date on it.
What's the preference stack? Investors get paid back first — sometimes 1x, sometimes more, sometimes with participation. A company that raised $200M and sells for $250M sounds like a win until you realize the stack ate $200M and common shareholders split scraps. Every equity horror story I've heard from a product leader in the last decade was, underneath, a preference-stack story. Ask for the stack. A company that won't share it is answering your question.
How much dilution is coming? Your 0.8% is 0.8% today. Two more rounds at 20% dilution each and it's 0.51% before you've finished vesting. Model your grant at the company's own target exit valuation, after the dilution their own fundraising plan implies. If they haven't done that math, do it for them in the room. It changes the negotiation instantly, because now you're both pricing the same asset.
What did the last equity payout actually look like? Companies with a real track record of secondary sales or tender offers are giving you an instrument with occasional liquidity. Companies without one are giving you paper with a decade horizon. Both can be fine. They are not the same price.
The 1x Test
Here is the simplest filter I know, and I've watched it save careers: would you take this job if the equity pays exactly zero? Not "less than hoped." Zero. If the cash, the scope, the team, and the next-role positioning still clear your bar at zero equity, take the swing — the upside is free optionality on a job you wanted anyway. If the offer only works when the equity works, you're not negotiating a compensation package; you're buying a lottery ticket with four years of your prime operating life. Most startup equity pays zero or near it. The executives who've done this a few times price that base rate in. The ones on their first rodeo price the pitch deck.
What the Mix Should Look Like at Each Stage
The cash-equity ratio is a function of stage, and fighting the stage is usually a mistake — the useful move is knowing which trade you're making.
- Seed to Series A: Deep below-market cash, meaningful single-digit equity for C-level hires. You are underwriting the company with your salary gap. Only rational if the 1x test passes and the equity is real ownership, not a gesture.
- Series B–C: The classic trade. A VP of Engineering in Austin at this stage typically takes 0.5–1.5% and below-market cash against a national cash band with a median around $231k. The title hides a 2x total-comp spread depending on how that trade lands.
- Late-stage private: Cash approaches market, equity shifts toward RSU-style grants. This is where the preference stack matters most, because the company raised a lot of money at a high price and you're behind all of it.
- Public company: Full-market cash plus RSUs. A Software Engineering Manager in Seattle lives this reality: big-tech total comp can double the local market through equity while the base salary gap stays modest. The equity is real, liquid, and still not guaranteed — it's just guaranteed to be worth something.
Note what's absent from that list: any stage where taking below-market cash and below-market equity is the deal. That offer exists. Decline it.
Refresh Grants and the Year-Three Cliff
The initial grant is the headline; the refresh policy is the plot. Most initial grants vest over four years, which means by year three your remaining unvested value is thinning fast. Companies with disciplined refresh programs top you up annually and year-three comp grows. Companies without them let it quietly collapse — and the market calls it the year-three cliff, because that's when their best people leave. Ask for the refresh policy in writing before you sign, not in your first comp review. For a VP of Finance — someone who will see the cap table anyway — asking early also signals you know how this movie ends. The refresh grant policy matters more than the initial grant by year three. Every experienced operator I know negotiates it up front; every disappointed one wishes they had.
Double-Trigger Acceleration, or: Plan for the Acquisition
Companies get bought. When they do, senior leaders are frequently redundant — the acquirer has its own CTO, its own sales leadership. Double-trigger acceleration (change of control plus termination vests your remaining equity) is the standard protection, and at the executive level it is not a nice-to-have. Asking for it signals you've been in the room before; a company that resists is telling you how they plan to treat you in the one scenario where your interests and theirs diverge most. Single-trigger is rare and acquirers hate it. Double-trigger is table stakes. An SVP of Sales in New York should go one step further and tie vesting acceleration to revenue milestones, not just tenure — you are the variable most correlated with the valuation, and your equity should know that.
Taxes: The Ten-Thousand-Foot View
General principles only, and then hire a professional. ISOs can qualify for long-term capital gains treatment if you hold long enough after exercise — but exercising can trigger AMT on paper gains you haven't realized, which is how people end up owing real taxes on worthless stock. NSOs are taxed as ordinary income on the spread at exercise, no ambiguity, no AMT trap, no favorable treatment. RSUs are taxed as ordinary income when they vest, whether or not you sell — which means holding vested RSUs is an active decision to concentrate in your employer's stock with post-tax money. Timing decisions — early exercise, 83(b) elections, exercise windows after departure — can swing outcomes by six figures in either direction. This paragraph is a map, not a route: talk to your tax advisor before you exercise anything.
The Portfolio View: Your Career Is the Fund
The last mental shift is the one that separates the executives who compound wealth from the ones who accumulate war stories. Any single equity grant is a coin flip you don't control. A thirty-year career is a portfolio of eight or ten bets, and you do control the allocation. Take the cash when your personal balance sheet is thin — kids, mortgage, a spouse's career in transition — or when the company's equity story fails the four questions above. Take the swing when you can survive the zero: when your base covers your life, when the stage is early enough for the equity to be real ownership, and when the operating role itself advances you even in the failure case. One or two well-chosen swings in a career is plenty. What kills people is taking the swing every time by default, or never taking it out of fear. Cash pays for the life you have. Equity, priced honestly and taken deliberately, pays for the one you're building. Know which one each offer is actually selling you — and make them show their math before you buy.